1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Anaplastic Oligoastrocytoma Global Clinical Trials Review, H1, 2014

Anaplastic Oligoastrocytoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Anaplastic Oligoastrocytoma Global Clinical Trials Review, H1, 2014" provides data on the Anaplastic Oligoastrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Oligoastrocytoma . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Oligoastrocytoma . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Anaplastic Oligoastrocytoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Anaplastic Oligoastrocytoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Anaplastic Oligoastrocytoma 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Anaplastic Oligoastrocytoma Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Tocagen Inc. 29
Clinical Trial Overview of Tocagen Inc. 29
Shandong Lanjin Pharmaceuticals Co. Ltd 30
Clinical Trial Overview of Shandong Lanjin Pharmaceuticals Co. Ltd 30
Insys Therapeutics, Inc. 31
Clinical Trial Overview of Insys Therapeutics, Inc. 31
Keryx Biopharmaceuticals, Inc. 32
Clinical Trial Overview of Keryx Biopharmaceuticals, Inc. 32
Biogen Idec Inc. 33
Clinical Trial Overview of Biogen Idec Inc. 33
Clinical Trial Overview of Top Institutes / Government 34
National Cancer Institute 34
Clinical Trial Overview of National Cancer Institute 34
Memorial Sloan Kettering Cancer Center 35
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 35
City of Hope National Medical Center 36
Clinical Trial Overview of City of Hope National Medical Center 36
Barbara Ann Karmanos Cancer Institute 37
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 37
Radiation Therapy Oncology Group 38
Clinical Trial Overview of Radiation Therapy Oncology Group 38
Rush University Medical Center 39
Clinical Trial Overview of Rush University Medical Center 39
University of Washington 40
Clinical Trial Overview of University of Washington 40
Hopitaux Universitaires de Geneve 41
Clinical Trial Overview of Hopitaux Universitaires de Geneve 41
University of California, San Diego 42
Clinical Trial Overview of University of California, San Diego 42
Five Key Clinical Profiles 43
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 80

List of Tables
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Anaplastic Oligoastrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Anaplastic Oligoastrocytoma Therapeutics, Global, Suspended Clinical Trials, 2014* 22
Anaplastic Oligoastrocytoma Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Anaplastic Oligoastrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tocagen Inc., 2014* 29
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong Lanjin Pharmaceuticals Co. Ltd, 2014* 30
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2014* 31
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Keryx Biopharmaceuticals, Inc., 2014* 32
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 33
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 34
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 35
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 36
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014* 37
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 38
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2014* 39
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 40
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2014* 41
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 42

List of Figures
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Anaplastic Oligoastrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Anaplastic Oligoastrocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 16
Anaplastic Oligoastrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Anaplastic Oligoastrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Anaplastic Oligoastrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Anaplastic Oligoastrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.